Evidence map›Paper›PMID 42631010›Full record

ArticleFrontiers in veterinary science2026

Development and validation of a Quality of Life and Treatment Satisfaction measure in feline osteoarthritis.

Edwina Gildea, Jill Thompson, Alasdair Cook, George Skingley, Amy Findley, Charlotte Panter, Thaisa Lucas Sandri, Aoife Mahon-Smith, Aoife Lydon

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edwina GildeaGlobal Medical Affairs, Zoetis Inc., Parsippany, NJ, United States.
Jill ThompsonDigital, Data and Analytics, Zoetis Inc., Parsippany, NJ, United States.
Alasdair CookVeterinary Health Innovation Engine (vHive), University of Surrey, Guildford, United Kingdom.
George SkingleyPatient-Centered Outcomes, Adelphi Values Ltd., Bollington, United Kingdom.
Amy FindleyPatient-Centered Outcomes, Adelphi Values Ltd., Bollington, United Kingdom.
Charlotte PanterPatient-Centered Outcomes, Adelphi Values Ltd., Bollington, United Kingdom.
Thaisa Lucas SandriGlobal Medical Affairs, Zoetis Inc., Parsippany, NJ, United States.
Aoife Mahon-SmithPatient-Centered Outcomes, Adelphi Values Ltd., Bollington, United Kingdom.
Aoife LydonPatient-Centered Outcomes, Adelphi Values Ltd., Bollington, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Osteoarthritis (OA) in cats causes pain and mobility impairment, negatively impacting quality of life (QoL) of cats and their owners. Owner-perceived treatment satisfaction can influence treatment adherence and subsequent health outcomes for the cat. Currently, no OA-specific instrument for cats assesses all three concepts. This study aimed to address this gap by developing and psychometrically evaluating an owner-completed feline OA-specific measure-the "Feline OA Quality of Life and Treatment Satisfaction Assessment" (FeOA-QoL-TS-A)-to measure cat QoL, owner QoL, and owner treatment satisfaction. Methods: A mixed-methods approach was used. The draft FeOA-QoL-TS-A was developed using a conceptual model derived from an earlier meta-synthesis of published literature and supplementary review. Qualitative interviews were then conducted with eight owners of cats with OA to evaluate the content validity of the draft FeOA-QoL-TS-A. The revised FeOA-QoL-TS-A was then administered to owners of OA-treated cats ( Results: Interview findings informed revisions to the draft 25-item FeOA-QoL-TS-A, which was well understood by owners. Item-level analysis and confirmatory factor analysis supported the removal of five items and confirmed the structure of three distinct domains: Cat QoL, Owner QoL, and Treatment Satisfaction. The final 20-item FeOA-QoL-TS-A demonstrated good internal consistency and test-retest reliability. Convergent validity was supported by strong correlations with concurrent measures. Known groups comparisons provided strong evidence that the instrument can differentiate between groups with varying QoL levels. Ability to detect improvement in Cat and Owner QoL domains was demonstrated through statistically significant improvements over time, with larger effect sizes reported for the 'improved' group compared with the 'stable' group. Anchor-based analyses supported -1.0 and -0.9-point responder definitions for Cat and Owner QoL domains, respectively. Conclusion: The final 20-item FeOA-QoL-TS-A is a valid, reliable, and responsive instrument for assessing OA-specific cat QoL, owner QoL, and treatment satisfaction. Its flexible domain structure supports application in veterinary practice, stakeholder communications, and clinical research endpoints. The FeOA-QoL-TS-A addresses a critical measurement gap by providing a comprehensive and practical solution to evaluate the multifaceted impacts of feline OA.

Indexed as

catfelineosteoarthritisownerpainpain managementQuality of LifeTreatment Satisfaction

Identifiers

PMID42631010
PMCPMC13495205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.